Journey Medical's Breakout Year: A Cautionary Tale of Earnings Growth Journey Medical Corporation's Q2 2026 earnings report has raised concerns among investors.
The company's positive EBITDA and increasing revenue are welcome news, but they mask some worrying trends that require attention. The reliance on Amrozi revenue is one such trend.
This product's 23% year over year increase in total net product revenue contributes significantly to the company's growth, but it also raises questions about sustainability.